<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="atom.xsl"?>
<feed xmlns="http://www.w3.org/2005/Atom">
       <title>Pfizer			
 - livepress.com</title>
      <link>http://pfizer.livepress.com</link>
			<id>http://pfizer.livepress.com</id>
  <updated>2006-07-30 19:25:36</updated>
  <entry>
    <title><![CDATA[New 'smart' cancer drug launched in Britain 
    (AFP)
]]></title>
    <link href="http://livepress.com/go/?129938"/>
    <id>http://livepress.com/go/?129938</id>
    <updated>2006-07-30 19:22:55</updated>
    <summary><![CDATA[    AFP - A new &quot;smart&quot;  cancer  drug that fights tumours on two fronts launches on Monday in Britain, according to The Times newspaper.  ]]></summary>
  </entry>
  <entry>
    <title><![CDATA[Pfizer Names Kindler To Replace McKinnell As CEO]]></title>
    <link href="http://livepress.com/go/?129747"/>
    <id>http://livepress.com/go/?129747</id>
    <updated>2006-07-30 08:32:02</updated>
    <summary><![CDATA[Pfizer Inc. names Vice Chairman Jeffrey B. Kindler as chief executive officer to replace Hank McKinnell, 63, who will remain chairman of the board of the world's largest drug company until his retirement in February 2007.
                    
                
                
                    ]]></summary>
  </entry>
  <entry>
    <title><![CDATA[Pfizer's Hank McKinnell replaced as CEO 
    (Reuters)
]]></title>
    <link href="http://livepress.com/go/?129220"/>
    <id>http://livepress.com/go/?129220</id>
    <updated>2006-07-28 21:57:38</updated>
    <summary><![CDATA[    Reuters -  Pfizer  Inc.  abruptly replaced 
Chief Executive Hank McKinnell on Friday, selecting its top 
lawyer, Jeffrey Kindler, to run the world's largest drugmaker.  ]]></summary>
  </entry>
  <entry>
    <title><![CDATA[Pfizer To Replace CEO With Its Top Lawyer]]></title>
    <link href="http://livepress.com/go/?129212"/>
    <id>http://livepress.com/go/?129212</id>
    <updated>2006-07-28 21:27:22</updated>
    <summary><![CDATA[Drug maker  Pfizer  Inc. has replaced CEO Hank McKinnell on Friday, and quickly announced attorney Jeffrey Kindler as his successor to run the company. McKinnell's abrupt departure from the world's largest drug maker comes after dismay from investors over a declining stock price and impending...]]></summary>
  </entry>
  <entry>
    <title><![CDATA[Pfizer's Kindler replaces McKinnell as CEO 
    (AP)
]]></title>
    <link href="http://livepress.com/go/?129153"/>
    <id>http://livepress.com/go/?129153</id>
    <updated>2006-07-28 20:11:10</updated>
    <summary><![CDATA[    AP -  Pfizer  Inc. said Friday it named Vice Chairman Jeffrey B. Kindler as chief executive officer to replace Hank McKinnell, 63, who will remain chairman of the board of the world's largest drug company until his retirement in February 2007.  ]]></summary>
  </entry>
  <entry>
    <title><![CDATA[Pfizer names Kindler to replace McKinnell 
    (AP)
]]></title>
    <link href="http://livepress.com/go/?129116"/>
    <id>http://livepress.com/go/?129116</id>
    <updated>2006-07-28 18:42:58</updated>
    <summary><![CDATA[    AP -  Pfizer  Inc. said Friday it named Vice Chairman Jeffrey B. Kindler as chief executive officer to replace Hank McKinnell, 63, who will remain chairman of the board of the world's largest drug company until his retirement in February 2007.  ]]></summary>
  </entry>
  <entry>
    <title><![CDATA[Pfizer board meeting discusses CEO succession 
    (Reuters)
]]></title>
    <link href="http://livepress.com/go/?129047"/>
    <id>http://livepress.com/go/?129047</id>
    <updated>2006-07-28 16:24:04</updated>
    <summary><![CDATA[    Reuters -  Pfizer  Inc.'s  board of 
directors was meeting on Friday to discuss plans for picking a 
successor to the company's chairman and chief executive, Hank 
McKinnell, who is scheduled to retire in February 2008.  ]]></summary>
  </entry>
  <entry>
    <title><![CDATA[Pfizer Earnings Rise On Sales Growth]]></title>
    <link href="http://livepress.com/go/?123902"/>
    <id>http://livepress.com/go/?123902</id>
    <updated>2006-07-20 17:15:36</updated>
    <summary><![CDATA[Pfizer beat analyst expectations on Thursday when its earnings jumped for the second quarter as sales surged, led by the world's top-selling drug, Lipitor. The stock price for  Pfizer , the world's biggest drug maker, rose more than 2 percent in morning trading....]]></summary>
  </entry>
  <entry>
    <title><![CDATA[Pfizer profit rises on sales 
    (Reuters)
]]></title>
    <link href="http://livepress.com/go/?123532"/>
    <id>http://livepress.com/go/?123532</id>
    <updated>2006-07-20 07:09:38</updated>
    <summary><![CDATA[Reuters -  Pfizer  Inc.  on Thursday said 
second-quarter earnings from continuing operations rose on 
higher sales of its prescription drugs.]]></summary>
  </entry>
  <entry>
    <title><![CDATA[Pfizer Faces 17 New Lawsuits In Connection With Lipitor Drug]]></title>
    <link href="http://livepress.com/go/?123096"/>
    <id>http://livepress.com/go/?123096</id>
    <updated>2006-07-17 20:05:10</updated>
    <summary><![CDATA[Multiple lawsuits have been filed against  Pfizer  in connection with its drug, Lipitor. Friday, 17 personal injury cases were filed in the New York State Supreme Court, by plaintiffs in California, Connecticut, Massachusetts, Michigan, New Jersey, New York and Virginia, claiming the drug caused...]]></summary>
  </entry>
  <entry>
    <title><![CDATA[Drug cos. set sights on diabetes care 
    (AP)
]]></title>
    <link href="http://livepress.com/go/?118239"/>
    <id>http://livepress.com/go/?118239</id>
    <updated>2006-07-04 22:47:01</updated>
    <summary><![CDATA[AP - Drug companies are racing to capture the ballooning market in  diabetes  care.  Pfizer  Inc. plans to debut Exubera, its new inhaled insulin treatment, in July, and  Merck  &amp; Co., Novartis AG and  Eli Lilly  and Co. are awaiting FDA approval for new  diabetes  products that could generate hundreds of millions of dollars in sales.]]></summary>
  </entry>
  <entry>
    <title><![CDATA[Drug cos. set sights on diabetes care 
    (AP)
]]></title>
    <link href="http://livepress.com/go/?117992"/>
    <id>http://livepress.com/go/?117992</id>
    <updated>2006-07-04 12:40:36</updated>
    <summary><![CDATA[AP - Drug companies are racing to capture the ballooning market in diabetes care.  Pfizer  Inc. plans to debut Exubra, its new inhaled insulin treatment, in July, and  Merck  &amp; Co., Novartis AG and Eli Lilly and Co. are awaiting FDA approval for new diabetes products that could generate hundreds of millions of dollars in sales.]]></summary>
  </entry>
  <entry>
    <title><![CDATA[Pfizer To Launch Generic Version Of Zoloft]]></title>
    <link href="http://livepress.com/go/?115427"/>
    <id>http://livepress.com/go/?115427</id>
    <updated>2006-06-29 13:28:02</updated>
    <summary><![CDATA[Global pharmaceutical giant  Pfizer  Inc. on Thursday announced its intention to introduce a generic version of its antidepressant Zoloft. The move is spurred by the arrival of a competitor's brand scheduled to hit the U.S. drug market by the weekend....]]></summary>
  </entry>
  <entry>
    <title><![CDATA[British Appeal Court Rules In Favor Of Pfizer In Lipitor Case]]></title>
    <link href="http://livepress.com/go/?114416"/>
    <id>http://livepress.com/go/?114416</id>
    <updated>2006-06-28 07:55:58</updated>
    <summary><![CDATA[Global pharmaceutical giant  Pfizer  Inc. says the United Kingdom's Court of Appeal has maintained a previous ruling in favor of the exclusivity of the main patent covering atorvastatin, the active ingredient in Lipitor.
                    
                
                
                    ]]></summary>
  </entry>
  <entry>
    <title><![CDATA[J&J wins Pfizer consumer health unit 
    (Reuters)
]]></title>
    <link href="http://livepress.com/go/?113454"/>
    <id>http://livepress.com/go/?113454</id>
    <updated>2006-06-27 01:07:44</updated>
    <summary><![CDATA[    Reuters - Johnson &amp; Johnson  said 
on Monday it would buy  Pfizer  Inc.&#039;s  consumer 
health-care business for &#36;16.6 billion in cash to increase its 
lead in the market for non-prescription health products.  ]]></summary>
  </entry>
  <entry>
    <title><![CDATA[Johnson & Johnson to buy Pfizer unit 
    (AP)
]]></title>
    <link href="http://livepress.com/go/?113130"/>
    <id>http://livepress.com/go/?113130</id>
    <updated>2006-06-26 15:16:01</updated>
    <summary><![CDATA[    AP - Johnson &amp;amp; Johnson said Monday it is buying  Pfizer  Inc.&#039;s consumer health care unit for &#36;16.6 billion in a nearly all-cash deal that strongly boosts J&amp;amp;J&#039;s smallest division.  ]]></summary>
  </entry>
  <entry>
    <title><![CDATA[Pfizer To Sell Consumer Health Unit For $16.6 Billion to Johnson &amp; Johnson]]></title>
    <link href="http://livepress.com/go/?112875"/>
    <id>http://livepress.com/go/?112875</id>
    <updated>2006-06-26 07:41:33</updated>
    <summary><![CDATA[Global pharmaceutical giant  Pfizer  Inc. announced on Monday it has agreed sell its consumer health care unit to Johnson &amp; Johnson for $16.6 billion.
                    
                
                
                    ]]></summary>
  </entry>
  <entry>
    <title><![CDATA[J&J wins Pfizer consumer health for $16.6 bln 
    (Reuters)
]]></title>
    <link href="http://livepress.com/go/?112851"/>
    <id>http://livepress.com/go/?112851</id>
    <updated>2006-06-26 07:11:28</updated>
    <summary><![CDATA[    Reuters -  Pfizer  Inc. said on Monday it had 
reached a definitive agreement to sell its consumer healthcare 
business to Johnson &amp; Johnson for &#36;16.6 billion in cash.  ]]></summary>
  </entry>
  <entry>
    <title><![CDATA[J&J close to $16 billion buy of Pfizer unit: NYT 
    (Reuters)
]]></title>
    <link href="http://livepress.com/go/?112719"/>
    <id>http://livepress.com/go/?112719</id>
    <updated>2006-06-26 00:22:17</updated>
    <summary><![CDATA[Reuters -  Johnson & Johnson  is close to reaching 
a deal to buy the consumer products unit of  Pfizer , which 
includes brands like Listerine and Sudafed, for more than $16 
billion, The  New York Times  online edition reported on Sunday.]]></summary>
  </entry>
  <entry>
    <title><![CDATA[J&J close to $16 billion buy of Pfizer consumer unit: NYT 
    (Reuters)
]]></title>
    <link href="http://livepress.com/go/?112617"/>
    <id>http://livepress.com/go/?112617</id>
    <updated>2006-06-25 18:49:17</updated>
    <summary><![CDATA[Reuters -  Johnson & Johnson   is close to 
reaching a deal to buy the consumer product unit of  Pfizer  
, which includes brands like Listerine and Sudafed, for 
more than $16 billion, The  New York Times  online edition 
reported on Sunday.]]></summary>
  </entry>
  <entry>
    <title><![CDATA[Zocor and Zoloft Patents To Expire]]></title>
    <link href="http://livepress.com/go/?111760"/>
    <id>http://livepress.com/go/?111760</id>
    <updated>2006-06-23 17:02:50</updated>
    <summary><![CDATA[Zocor, a cholesterol-cutting drug from  Merck  and Zoloft, antidepressant from  Pfizer  are going off patent this month. Merck's patent for Zocor expires Friday while Zoloft loses patent protection on June 30.
                    
                
                
                    ]]></summary>
  </entry>
  <entry>
    <title><![CDATA[Ultra-cheap drugs worry generic makers 
    (AP)
]]></title>
    <link href="http://livepress.com/go/?110405"/>
    <id>http://livepress.com/go/?110405</id>
    <updated>2006-06-21 19:19:34</updated>
    <summary><![CDATA[    AP - It&#039;s a novel approach in the long battle between brand name drugs and their generic rivals:  Merck  &amp;amp; Co. is slashing the price of its  cholesterol  drug Zocor so low for one insurance plan that members will actually pay less for the original pills than for the generic.  ]]></summary>
  </entry>
  <entry>
    <title><![CDATA[Chinese firms appeal Viagra patent ruling 
    (AFP)
]]></title>
    <link href="http://livepress.com/go/?109222"/>
    <id>http://livepress.com/go/?109222</id>
    <updated>2006-06-20 07:41:08</updated>
    <summary><![CDATA[    AFP - Chinese drug firms have appealed a court ruling upholding US pharmaceutical giant  Pfizer &#039;s China patent for its impotency drug Viagra, both sides have said.  ]]></summary>
  </entry>
  <entry>
    <title><![CDATA[GE Healthcare bids for Biacore, Pfizer accepts 
    (Reuters)
]]></title>
    <link href="http://livepress.com/go/?109221"/>
    <id>http://livepress.com/go/?109221</id>
    <updated>2006-06-20 07:41:07</updated>
    <summary><![CDATA[    Reuters - GE Healthcare  said on Tuesday 
it had made a recommended 3.22 billion Swedish crown (&#36;436.3 
million) cash offer for Swedish medical instruments maker 
Biacore .  ]]></summary>
  </entry>
  <entry>
    <title><![CDATA[China pharmaceuticals appeal Viagra ruling 
    (AP)
]]></title>
    <link href="http://livepress.com/go/?109060"/>
    <id>http://livepress.com/go/?109060</id>
    <updated>2006-06-20 01:07:58</updated>
    <summary><![CDATA[AP - Twelve Chinese pharmaceutical companies are appealing a court ruling that sides with  Pfizer  Inc. and prevents local drug makers from selling generic versions of Viagra, a state-run newspaper said Tuesday.]]></summary>
  </entry>
</feed>